The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery

IMPORTANCE: Studies on the prognostic role of hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei (PMP) are currently not available. OBJECTIVES: To evaluate outcomes after cytoreductive surgery (CRS) and HIPEC compared with CRS alone in patients with PMP. DESIGN, SETTING, AND...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Surg
Autors principals: Kusamura, Shigeki, Barretta, Francesco, Yonemura, Yutaka, Sugarbaker, Paul Hendrick, Moran, Brendan John, Levine, Edward A., Goere, Diane, Baratti, Dario, Nizri, Eran, Morris, David Lawson, Glehen, Olivier, Sardi, Armando, Barrios, Pedro, Quénet, François, Villeneuve, Laurent, Gómez-Portilla, Alberto, de Hingh, Ignace, Ceelen, Wim, Pelz, Joerg O. W., Piso, Pompiliu, González-Moreno, Santiago, Van Der Speeten, Kurt, Deraco, Marcello
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2021
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7841579/
https://ncbi.nlm.nih.gov/pubmed/33502455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamasurg.2020.6363
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars